FDA.reportPublic FDA data

levomilnacipran 40 MG (as levomilnacipran hydrochloride 45.9 MG) 24 HR Extended Release Oral Capsule

RxCUI
1433233
RxNorm name
levomilnacipran 40 MG (as levomilnacipran hydrochloride 45.9 MG) 24 HR Extended Release Oral Capsule
Display name
levomilnacipran 40 MG (as levomilnacipran hydrochloride 45.9 MG) 24 HR Extended Release Oral Capsule
Full name
levomilnacipran 40 MG (as levomilnacipran hydrochloride 45.9 MG) 24 HR Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FetzimaLEVOMILNACIPRAN HYDROCHLORIDEAllergan, Inc.f371258d-91b3-4b6a-ac99-434a1964c3af2024-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1433233

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f371258d-91b3-4b6a-ac99-434a1964c3aflevomilnacipran 40 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR levomilnacipran 40 MG Extended Release Oral Capsule [SCD] · levomilnacipran 40 MG (as levomilnacipran hydrochloride 45.9 MG) 24 HR Extended Release Oral Capsule [SY] · levomilnacipran 40 MG 24HR Extended Release Oral Capsule [SY]433These highlights do not include all the information needed to use FETZIMA safely and effectively. See full prescribing information for FETZIMA . FETZIMA ® ( levomilnacipran ) extended -release capsules, for oral use Initial U.S. Approval: 2009 (milnacipran)20240430